Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: Results after 1 year.
TLM
anterior commissure involvement
early glottic cancer
laser surgery
voice outcome
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
08
01
2018
revised:
22
08
2018
accepted:
07
12
2018
pubmed:
18
1
2019
medline:
9
9
2020
entrez:
18
1
2019
Statut:
ppublish
Résumé
Voice outcome was assessed in patients with extended T1 and limited T2 glottic carcinoma, treated with a unilateral type III or a bilateral type II resection according to the European Laryngological Society (ELS) classification. Objective evaluation (acoustic and aerodynamic parameters), perceptual evaluation (GRBAS), and patients' self-assessment (voice handicap index [VHI]) were performed before and 1 year after treatment. Results were evaluated according to ELS resection type and the involvement of the anterior commissure. The majority of voice parameters in all resection subgroups showed an improvement of the mean score 1 year postoperatively. Grade of dysphonia varied between 1.15 and 1.66 postoperatively and VHI score varied from 23.3 to 24.5. Voice outcome after ELS unilateral type III or a bilateral type II resection for extended T1 and limited T2 glottic carcinoma is good with mild to very moderate perceptive dysphonia and low self-reported voice impairment.
Sections du résumé
BACKGROUND
Voice outcome was assessed in patients with extended T1 and limited T2 glottic carcinoma, treated with a unilateral type III or a bilateral type II resection according to the European Laryngological Society (ELS) classification.
METHODS
Objective evaluation (acoustic and aerodynamic parameters), perceptual evaluation (GRBAS), and patients' self-assessment (voice handicap index [VHI]) were performed before and 1 year after treatment. Results were evaluated according to ELS resection type and the involvement of the anterior commissure.
RESULTS
The majority of voice parameters in all resection subgroups showed an improvement of the mean score 1 year postoperatively. Grade of dysphonia varied between 1.15 and 1.66 postoperatively and VHI score varied from 23.3 to 24.5.
CONCLUSION
Voice outcome after ELS unilateral type III or a bilateral type II resection for extended T1 and limited T2 glottic carcinoma is good with mild to very moderate perceptive dysphonia and low self-reported voice impairment.
Identifiants
pubmed: 30652373
doi: 10.1002/hed.25582
pmc: PMC6590407
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1638-1647Subventions
Organisme : ZOLEON, Stichting Oncologie Haaglanden West, Leiden, the Netherlands
Pays : International
Informations de copyright
© 2019 The Authors. Head & Neck published by Wiley Periodicals, Inc.
Références
Laryngoscope. 2015 Aug;125(8):1892-9
pubmed: 26010240
Eur Arch Otorhinolaryngol. 2012 Jun;269(6):1647-52
pubmed: 22310839
J Voice. 2012 May;26(3):381-9
pubmed: 21840171
Ann Otol Rhinol Laryngol. 2003 Feb;112(2):174-9
pubmed: 12597292
J Laryngol Otol. 2011 Dec;125(12):1251-5
pubmed: 22018209
Ann Otol Rhinol Laryngol. 2018 Mar;127(3):139-145
pubmed: 29291278
Otolaryngol Pol. 2012 Nov-Dec;66(6):407-12
pubmed: 23200562
Cancer. 2006 Jan 1;106(1):95-105
pubmed: 16323175
Laryngoscope. 2017 Jun;127(6):1322-1327
pubmed: 27778345
Laryngoscope. 2006 Jun;116(6):1007-11
pubmed: 16735886
J Laryngol Otol. 2011 Jul;125(7):706-13
pubmed: 21481298
Eur Arch Otorhinolaryngol. 2013 Aug;270(8):2275-81
pubmed: 23568037
Head Neck. 2009 Jun;31(6):759-64
pubmed: 19260127
Ann Otol Rhinol Laryngol. 2003 Sep;112(9 Pt 1):759-63
pubmed: 14535558
Eur Arch Otorhinolaryngol. 2018 Sep;275(9):2333-2340
pubmed: 30027440
Folia Phoniatr Logop. 2008;60(4):173-8
pubmed: 18434740
J Speech Lang Hear Res. 2000 Jun;43(3):796-809
pubmed: 10877446
ORL J Otorhinolaryngol Relat Spec. 2013;75(1):18-26
pubmed: 23549104
Laryngoscope. 2016 Feb;126(2):405-7
pubmed: 26597360
Head Neck. 2019 Jun;41(6):1638-1647
pubmed: 30652373
Head Neck. 2012 Jan;34(1):23-33
pubmed: 21374753
J Voice. 2012 Sep;26(5):596-601
pubmed: 22483247
Curr Opin Otolaryngol Head Neck Surg. 2018 Apr;26(2):84-93
pubmed: 29278552
Acta Otolaryngol. 2007 Jun;127(6):637-41
pubmed: 17503234
Eur Arch Otorhinolaryngol. 2010 May;267(5):743-50
pubmed: 19898826
Clin Otolaryngol. 2005 Feb;30(1):42-7
pubmed: 15748189
J Voice. 2000 Jun;14(2):161-9
pubmed: 10875567
Eur Arch Otorhinolaryngol. 2008 May;265(5):543-8
pubmed: 17999074
Braz J Otorhinolaryngol. 2006 May-Jun;72(3):295-301
pubmed: 17119763
Eur Arch Otorhinolaryngol. 2000;257(4):227-31
pubmed: 10867840
Strahlenther Onkol. 2010 Nov;186(11):607-13
pubmed: 21069268
Otolaryngol Head Neck Surg. 2015 May;152(5):811-9
pubmed: 25837666
Eur Arch Otorhinolaryngol. 2015 Feb;272(2):413-8
pubmed: 25351502
J Otolaryngol Head Neck Surg. 2013 Mar 19;42:22
pubmed: 23672802
J Speech Hear Disord. 1981 May;46(2):147-9
pubmed: 7253591
J Voice. 2006 Sep;20(3):369-79
pubmed: 16242300
Eur Arch Otorhinolaryngol. 2007 Sep;264(9):1033-8
pubmed: 17457601
Cochrane Database Syst Rev. 2014 Dec 12;(12):CD002027
pubmed: 25503538
Otolaryngol Clin North Am. 2015 Aug;48(4):627-37
pubmed: 26096137
Head Neck. 2007 Nov;29(11):1010-6
pubmed: 17510971
Head Neck. 2012 Sep;34(9):1294-8
pubmed: 22084017
Int J Surg. 2014 Dec;12(12):1500-24
pubmed: 25046751
Laryngoscope. 2016 Sep;126(9):2051-6
pubmed: 26934846
Acta Otorhinolaryngol Belg. 1996;50(4):353-60
pubmed: 9001645
Curr Otorhinolaryngol Rep. 2017;5(1):56-68
pubmed: 28367361
Head Neck. 2013 Mar;35(3):376-80
pubmed: 22367882
Head Neck. 2008 Jan;30(1):43-9
pubmed: 17636543
Radiother Oncol. 2009 Feb;90(2):177-82
pubmed: 18937990
J Voice. 2012 Nov;26(6):801-5
pubmed: 22717493